Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 32,387 articles published since 2008
|||| 50 

These are the 32387 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
451 Editorial Regional chemotherapy for pancreatic cancer. 2011

Avital, Itzhak. · ·J Surg Oncol · Pubmed #21618244.

ABSTRACT: -- No abstract --

452 Editorial HOX genes in pancreatic development and cancer. 2011

Gray, Sophie / Pandha, Hardev S / Michael, Agnieszka / Middleton, Gary / Morgan, Richard. · ·JOP · Pubmed #21546695.

ABSTRACT: The HOX genes are a family of homeodomain-containing transcription factors that determine cellular identity during development and which are subsequently re-expressed in many types of cancer. Some recent studies have shown that HOX genes may have key roles both in pancreatic development and in adult diseases of the pancreas, including cancer. In this review we consider recent advances in elucidating the role of HOX genes in these processes, how they may connect early developmental events to subsequent adult disease, and their potential both as diagnostic markers and therapeutic targets.

453 Editorial Pancreatic cancer surveillance: learning as we go. 2011

Brentnall, Teresa A. · ·Am J Gastroenterol · Pubmed #21540900.

ABSTRACT: The concept of pancreatic cancer prevention through surveillance of high-risk patients has come of age. It is cost-effective to provide surveillance of patients who have a lifetime risk of pancreatic cancer that is ≥16%. Studies are currently ongoing that contribute to our understanding of the imaging methodologies that are best suited for surveillance and the best algorithm for the clinical management of patients who are at risk of this highly lethal disease. Long-term outcomes analyses will help shed light on the best management of these patients, as well as a better understanding of the natural history of familial pancreatic cancer.

454 Editorial Emerging therapeutic targets and agents for pancreatic cancer therapy--where are we and where we have to go? 2011

Sebens, Susanne / Kalthoff, Holger. · ·Anticancer Agents Med Chem · Pubmed #21492077.

ABSTRACT: -- No abstract --

455 Editorial Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer. 2011

Grassetto, Gaia / Rubello, Domenico. · ·Am J Clin Oncol · Pubmed #21483236.

ABSTRACT: -- No abstract --

456 Editorial Walk closer or carry big glass? Comparing EUS and multidetector CT. 2011

Owens, Michael M. · ·Gastrointest Endosc · Pubmed #21457814.

ABSTRACT: -- No abstract --

457 Editorial 18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed? 2011

Nguyen, Nam Q / Bartholomeusz, Dylan F. · ·J Gastroenterol Hepatol · Pubmed #21418296.

ABSTRACT: -- No abstract --

458 Editorial [Pancreatic cancer--association with diabetes mellitus and smoking]. 2011

Vavrecka, A. · ·Vnitr Lek · Pubmed #21416850.

ABSTRACT: -- No abstract --

459 Editorial MicroRNAs in pancreatic ductal adenocarcinoma. 2011

Park, Jong Y / Helm, James / Coppola, Domenico / Kim, Donghwa / Malafa, Mokenge / Kim, Seung Joon. · ·World J Gastroenterol · Pubmed #21412491.

ABSTRACT: Ductal adenocarcinoma of the pancreas is a lethal cancer for which the only chance of long-term survival belongs to the patient with localized disease in whom a potentially curative resection can be done. Therefore, biomarkers for early detection and new therapeutic strategies are urgently needed. miRNAs are a recently discovered class of small endogenous non-coding RNAs of about 22 nucleotides that have gained attention for their role in downregulation of mRNA expression at the post-transcriptional level. miRNAs regulate proteins involved in critical cellular processes such as differentiation, proliferation, and apoptosis. Evidence suggests that deregulated miRNA expression is involved in carcinogenesis at many sites, including the pancreas. Aberrant expression of miRNAs may upregulate the expression of oncogenes or downregulate the expression of tumor suppressor genes, as well as play a role in other mechanisms of carcinogenesis. The purpose of this review is to summarize our knowledge of deregulated miRNA expression in pancreatic cancer and discuss the implication for potential translation of this knowledge into clinical practice.

460 Editorial Three-drug combination regimen in pancreatic cancer treatment: are we there yet? 2011

Kang, Soonmo Peter / Saif, Muhammad Wasif. · ·JOP · Pubmed #21386625.

ABSTRACT: -- No abstract --

461 Editorial Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress. 2011

Evans, Douglas B / Wolff, Robert A. · ·Ann Surg Oncol · Pubmed #21384245.

ABSTRACT: -- No abstract --

462 Editorial Timing is everything: Brca2 and p53 mutations in pancreatic cancer. 2011

Morton, Jennifer P / Steele, Colin W / Sansom, Owen J. · ·Gastroenterology · Pubmed #21352873.

ABSTRACT: -- No abstract --

463 Editorial Foreword: Gastroenteropancreatic system and its tumors: Part 2. 2011

LeRoith, Derek. ·Division of Endocrinology, Metabolism, and Bone Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. derek.leroith@mssm.edu ·Endocrinol Metab Clin North Am · Pubmed #21349407.

ABSTRACT: -- No abstract --

464 Editorial Pancreatic cancer. A multidisciplinary approach. 2011

López Martín, A / Carballo Alvarez, L F. · ·Rev Esp Enferm Dig · Pubmed #21341930.

ABSTRACT: -- No abstract --

465 Editorial [Pancreatic oncological surgery. Are the levels of excellence achievable?]. 2011

Sabater Ortí, Luis. · ·Cir Esp · Pubmed #21333973.

ABSTRACT: -- No abstract --

466 Editorial MiRegulators in cancer stem cells of solid tumors. 2011

Ma, Stephanie / Guan, Xin-Yuan. · ·Cell Cycle · Pubmed #21311235.

ABSTRACT: -- No abstract --

467 Editorial Promising advances in the treatment of malignant pancreatic endocrine tumors. 2011

Jensen, Robert T / Delle Fave, Gianfranco. · ·N Engl J Med · Pubmed #21306243.

ABSTRACT: -- No abstract --

468 Editorial Transcriptional control of gene expression in pancreatic cancer: from sequence-specific transcription factors to nuclear architecture. 2011

Ellenrieder, Volker / Fernandez-Zapico, Martin E. · ·J Gastrointest Cancer · Pubmed #21279553.

ABSTRACT: Transcription plays a central role in the regulation of gene expression during neoplastic transformation in different tissues. Using this nuclear process as a common topic in this special issue of the Journal of Gastrointestinal Cancer we have covered with five review articles key aspects of gene transcription and its impact in pancreatic carcinogenesis. We are confident that the knowledge included in these review articles will help understand the contribution of this molecular event to the pathogenesis of this devastating disease and serve as foundation for the development of new therapeutic tools.

469 Editorial Solid pseudopapillary tumor and wnt signaling pathway ... Way to go!? 2011

Sikora, Sadiq S / Vali, Shireen. · ·J Gastroenterol Hepatol · Pubmed #21261709.

ABSTRACT: -- No abstract --

470 Editorial The signal of suicide rates seen from a distance in patients with pancreatic cancer. 2011

Greenberg, Donna B. · ·Cancer · Pubmed #21254047.

ABSTRACT: -- No abstract --

471 Editorial Life, liberty, and the pursuit of quality-adjusted life-years after pancreatic cancer surgery. 2011

Adams, David B. · ·World J Surg · Pubmed #21249360.

ABSTRACT: -- No abstract --

472 Editorial Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma. 2011

Dimou, Anastasios / Syrigos, Kostas / Saif, Muhammad Wasif. · ·JOP · Pubmed #21206093.

ABSTRACT: The role of hedgehog pathway in the biology of pancreatic adenocarcinoma is an emerging area of investigation and provides a novel field for treatment intervention. Recent studies have shown the activation of the hedgehog pathway in pancreatic cancer. Despite the initial assumption of an autocrine mechanism, it seems that the hedgehog pathway contributes to the molecular conversation between tumor and its microenvironment through a paracrine loop. Furthermore, members of the hedgehog pathway crosstalk with other pathways; they regulate tumor angiogenesis and are associated with cancer stem cells. In addition, there is preclinical evidence about the efficiency of hedgehog inhibitors both in vitro and in vivo and the first clinical trials with those compounds in the treatment of patients with pancreatic adenocarcinoma, are already under way.

473 Editorial Yet another nucleoside analog for pancreatic cancer. 2011

Gandhi, Varsha. · ·Gastroenterology · Pubmed #21172332.

ABSTRACT: -- No abstract --

474 Editorial Operative blood loss and survival in pancreatic cancer. 2011

Donahue, Timothy R / Reber, Howard A. · ·Pancreas · Pubmed #21160368.

ABSTRACT: -- No abstract --

475 Editorial Borderline resectable pancreatic cancer: what have we learned and where do we go from here? 2011

Katz, Matthew H G / Pisters, Peter W T / Lee, Jeffrey E / Fleming, Jason B. · ·Ann Surg Oncol · Pubmed #21136179.

ABSTRACT: -- No abstract --

Back · Next